To sum up, CP@NP-cRGD could observably decrease proliferation and trigger apoptosis by impeding autophagy and the FGFR1 pathway in drug-resistant tumor, which provided a new strategy for reversing AZD9291 resistance. The gene discussed is FGFR1; the disease is neoplasm.